Genprex, Inc. (GETTEX:2DE) People

Genprex, Inc.

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
John N Bonfiglio
Other companies: Qrons Inc (Chief Operating Officer · Jul 1, 2019 – Jul 1, 2019 · Past); Marker Therapeutics, Inc. (President and COO, Director · Jul 23, 2015 – Mar 9, 2017 · Past); Oragenics Inc. (President and CEO, Director · May 25, 2011 – Aug 13, 2014 · Past); Harrow, Inc. (President and CEO, Director · Oct 20, 2010 – Oct 20, 2010 · Past)
Director · Feb 12, 2019 – Feb 12, 2019 · Past
Catherine M Vaczy
Other companies: Lisata Therapeutics, Inc. (General Counsel · Oct 31, 2008 – Apr 13, 2015 · Past)
EVP GC Chief Strategy Officer · Mar 12, 2020 – Apr 21, 2023 · Past
Mark Stanley Berger
Other companies: Actinium Pharmaceuticals, Inc. (Delaware) (Chief Medical Officer · Mar 16, 2017 – Sep 1, 2021 · Past)
Chief Medical Officer · Since at least Sep 27, 2021
Brent LongneckerDirector · Since at least Apr 14, 2026
Celina LaneyChief of Staff · Since at least Nov 5, 2026
Greg JancarikSenior Director and Corporate Controller · Since at least Nov 4, 2026
Hermant KumarChief Mfgr & Tech Officer · Sep 27, 2021 – Feb 18, 2023 · Past
John Rodney VarnerChairman, President and CEO, Director · Mar 28, 2018 – Feb 18, 2024 · Past
Jose A. Moreno ToscanoBoard Chairman · Since at least Nov 5, 2026
Kalyn DabbsDirector of Communications · Since at least Oct 28, 2026
Kate CombsVice President of Clinical Operations · Since at least Nov 4, 2026
Robert W PearsonDirector · Mar 28, 2018 – Dec 30, 2019 · Past
Ryan M. ConferPresident, Chief Executive Officer, Chief Financial Officer · Since at least Jul 28, 2022
Tracy HuynhAccounting Manager · Since at least Nov 5, 2026
William WilsonBoard Director · Since at least Nov 5, 2026